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Crystal structure of human glyoxalase II and its complex with a
glutathione thiolester substrate analogue
Alexander D Cameron1*†, Marianne Ridderström2, Birgit Olin2
and Bengt Mannervik2
Background: Glyoxalase II, the second of two enzymes in the glyoxalase
system, is a thiolesterase that catalyses the hydrolysis of S-D-lactoylglutathione
to form glutathione and D-lactic acid. 
Results: The structure of human glyoxalase II was solved initially by single
isomorphous replacement with anomalous scattering and refined at a resolution
of 1.9 Å. The enzyme consists of two domains. The first domain folds into a
four-layered β sandwich, similar to that seen in the metallo-β-lactamases. The
second domain is predominantly α-helical. The active site contains a binuclear
zinc-binding site and a substrate-binding site extending over the domain
interface. The model contains acetate and cacodylate in the active site. A
second complex was derived from crystals soaked in a solution containing the
slow substrate, S-(N-hydroxy-N-bromophenylcarbamoyl)glutathione. This
complex was refined at a resolution of 1.45 Å. It contains the added ligand in
one molecule of the asymmetric unit and glutathione in the other. 
Conclusions: The arrangement of ligands around the zinc ions includes a
water molecule, presumably in the form of a hydroxide ion, coordinated to both
metal ions. This hydroxide ion is situated 2.9 Å from the carbonyl carbon of the
substrate in such a position that it could act as the nucleophile during
catalysis. The reaction mechanism may also have implications for the action of
metallo-β-lactamases.
Introduction
The glyoxalase system catalyses the conversion of toxic
2-oxoaldehydes to the corresponding 2-hydroxycar-
boxylic acids using glutathione (GSH) as a coenzyme.
The system consists of two distinct enzymes, glyoxalase
I and glyoxalase II, and occurs in many organisms from
bacteria to man [1,2]. The substrate for glyoxalase I is
the thiohemiacetal produced when GSH reacts non-
enzymatically with a 2-oxoaldehyde (Figure 1). Glyox-
alase I catalyses the isomerisation of this thiohemiacetal
to produce the thiolester of GSH and the corresponding
2-hydroxycarboxylic acid. Glyoxalase II then catalyses
the hydrolysis of the thiolester to produce GSH and a
free 2-hydroxycarboxylic acid. The primary physiological
function of the glyoxalase system appears to be the
detoxication of methylglyoxal, which is produced as a
byproduct of metabolism [3]. A recent report indicates
that glyoxalase II may also be important in the regulation
of spermatogenesis [4]. The glyoxalase system has been
studied with regard to diabetes because the accumula-
tion of methylglyoxal in diabetics can lead to pathophysi-
ological complications (reviewed in [5]). It has also been
targeted in the design of novel anti-protozoal [6] and
anti-tumour drugs [7–9].
Previously we published the structure of human glyoxalase
I [10]. We now report the structure of human glyoxalase II
(EC 3.1.2.6). The enzyme is a monomer of molecular
weight 29 kDa and has no sequence similarity to glyox-
alase I. It has a broad specificity for thiolesters but a high
specificity for the glutathione moiety [11]. It has been
cloned and heterologously expressed in Escherichia coli
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Figure 1
The glyoxalase system. GSH represents reduced glutathione (γ-L-Glu-
L-Cys-Gly). 
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[12]. Recently, based on sequence homology, it has been
shown that glyoxalase II is a member of a superfamily of
hydrolases [13,14]. The family includes the metallo-β-lac-
tamases for which the structures from three sources have
been published [15–17]. These enzymes contain either a
mononuclear [15] or a binuclear [16,17] zinc-binding site.
Throughout the family, most of the residues involved in
coordination of the zinc ions in the metallo-β-lactamases
are conserved, suggesting that the glyoxalase II enzymes
may contain at least one metal-binding site [13]. Previ-
ously metal analyses had not been done on human glyox-
alase II but an examination of the enzyme from Arabidopsis
thaliana showed that the enzyme binds two moles of zinc
per mole of II and that zinc is essential for activity [18]. 
In the present investigation, the crystal structure of
human glyoxalase II has been solved by single isomor-
phous replacement combined with anomalous scattering.
Two complexes are described. The first contains acetate
and cacodylate ions, from the crystallisation mixture,
bound in the active site. The second is derived
from crystals soaked in a solution containing the slow
substrate S-(N-hydroxy-N-bromophenylcarbamoyl)glu-
tathione (HBPC–GSH) [19]. In this structure,
HBPC–GSH can be seen in one molecule of the asym-
metric unit and GSH, the product of the reaction, can be
seen in the other. 
Results and discussion
The structure of the enzyme containing acetate and
cacodylate was refined against data extending to a dmin of
1.9 Å, to an R factor of 18.5% (15–1.9 Å) and a correspond-
ing Rfree [20] of 23.9%. The final model contains all
residues from the two protein molecules of the asymmetric
unit, which are related by a local twofold axis. Associated
with each protein molecule are two zinc ions, an acetate
ion, a cacodylate ion and an arsenic atom covalently linked
to Cys153. There are a total of 369 water molecules. Two
Mn ions and one Cl ion bind at the interface between the
two molecules. The two molecules are very similar, with a
root mean square deviation (rmsd) in the positions of all
corresponding pairs of Cα atoms of 0.37 Å. The structure
of the enzyme in complex with HBPC–GSH was refined
against data extending to a resolution of 1.45 Å. The final
model has an R factor of 20.4% (20–1.45 Å), an Rfree of 23.2
and includes all protein residues, four zinc ions, one mole-
cule of HBPC–GSH, one molecule of GSH and 357 water
molecules. The rmsd in the positions of all corresponding
pairs of Cα atoms between the two molecules of the asym-
metric unit of this structure is 0.35 Å. Between the A mole-
cules of the two different complexes the rmsd is 0.22 Å,
whereas for the B molecules it is 0.25 Å. 
Overall structure
The protein consists of two structural domains (Figure 2a),
as was postulated by limited-proteolysis studies [21]. The
N-terminal domain, including residues 1–173, has the
topology of a four-layered β sandwich with two mixed
β sheets flanked by α helices. The first half of the sand-
wich has a βββαβαββ topology; the second folds as a
ββββαβ unit and is aligned at an angle of ~20° to the first
(Figure 2a). The βββαβ motif from the two halves
(β1β2β3α1β4 and β8β9β10α3β11) can be superimposed by a
twofold rotation. We can align 39 out of 57 pairs of Cα
atoms with an rmsd of 1.4 Å (see the Materials and
methods section). A structure-based sequence alignment
shows that the sequence identity from the N- and C-termi-
nal halves is ~14%. Residues 136–141, situated directly
after β10 form a β hairpin at an angle of approximately 80°
to the direction of β10 (Figure 2). This is part of an
extended loop structure that is not present in the N-termi-
nal half of the sandwich. The second domain is situated at
one edge of the first and consists of residues 174–260
folded into five α helices. That this domain would be pre-
dominantly α-helical was suggested from circular dichroism
studies [21]. Directly preceding helix α6, there is a short
section of chain that extends the second sheet of domain 1
by hydrogen bonding to β11. As can be seen from Figure 2,
the two domains interact very tightly. In particular, the
hairpin loop of the N-terminal domain protrudes into the
C-terminal domain and makes both hydrophobic and
hydrogen-bonding interactions with residues on helices α4
and α6. Altogether, the C-terminal domain buries ~1200 Å2
of the surface area belonging to the N-terminal domain.
The first domain of glyoxalase II is structurally similar to
the whole structure of the metallo-β-lactamases
(Figure 2). Within this domain, the rmsd in the positions
of 144 Cα atoms from the metallo-β-lactamase from Bac-
teroides fragilis [16] that can be superimposed to within
3.8 Å of the corresponding atoms of glyoxalase II is 1.7 Å
(see the Materials and methods section). Twenty-five
percent of the matched residues are identical in the two
sequences. In comparison to glyoxalase II, the N-terminal
sheet of the metallo-β-lactamases contains two extra
strands at the N terminus. This means that in these
enzymes the motif common to the two halves of the sand-
wich is slightly larger than that seen in glyoxalase II
(ββββαβα) [15]. Although there is only one domain in the
metallo-β-lactamases, there is a topologically equivalent
strand in these enzymes to the strand that hydrogen bonds
to β11 of glyoxalase II [22]. As in glyoxalase II, this strand
immediately precedes an α helix (α6 in glyoxalase II, the
C-terminal helix in the metallo-β-lactamase); however, it
follows directly on from the β sandwich rather than via the
α−α motif seen in glyoxalase II. As can be seen in
Figure 2, the β hairpin in glyoxalase II is replaced by a
gentler loop structure in the metallo-β-lactamases. 
Active site
Within each molecule there is clear electron density for a
binuclear metal site (Figure 3). Metal analysis shows that
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there are ~1.5 moles of zinc per mole of protein. Though
the results also show the presence of 0.7 moles of iron per
mole of protein, taken together with the metal-binding
studies on the A. thaliana enzyme [18], it seems that human
glyoxalase II is a zinc metalloenzyme. It is possible that the
zinc content is slightly less than expected because some
metal exchange occurred during purification. The metal-
binding site is situated at a topologically equivalent posi-
tion to that observed in the metallo-β-lactamases at one
edge of the β sandwich (Figure 2). One of the metal ions is
less than 1 Å from the rotation axis that would superimpose
one β sheet onto the other. The active site extends from
this metal-binding site across the domain interface.
HBPC–GSH is clearly defined in the structure derived
from the crystal soaked in this compound (Figure 3)
binding in a groove on the surface of the molecule.
However, it is only seen in one molecule of the asymmetric
unit. In the other molecule, glutathione, the product of the
reaction, can be observed. In the other structure obtained
from crystals grown in the presence of acetate and cacody-
late these entities are clearly seen in the active site of both
protein molecules. Arsenate ions have, in fact, been
reported to inhibit the enzyme [11]. 
Metal binding
The coordination sphere of the two metal ions varies
slightly depending on the ligand bound in the active site.
In all cases, seven protein residues and one water mole-
cule interact directly with the two zinc ions (Table 1,
Figure 4). The two metals are separated by a distance of
3.3–3.5 Å and are bridged by both a water molecule and
the Oδ1 atom of Asp134. The latter, however, appears to
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Figure 2
Overall structure of glyoxalase II and a
comparison with the metallo-β-lactamase. 
(a) Schematic representation of glyoxalase II.
The molecule has been colour ramped
according to residue number starting with
red at the N terminus and finishing with blue
at the C terminus. The β strands of the first
domain and the α helices of the second
domain have been labelled for clarity. The
metal ions and the coordinating residues are
represented by balls and sticks. The figure
was prepared using MolScript version 2.1
[54]. (b) Similar view of the metallo-β-
lactamase from B. fragilis [16] after it had
been superimposed on glyoxalase II. 
(c) Topology diagram of glyoxalase II. The
approximate position of the twofold axis
relating the two halves of the β sheet is
indicated. The numbering shows the N and
C termini, respectively, of each secondary
structure element. The secondary structural
elements were defined using the YASSPA
algorithm implemented in O [45].
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be in a less favourable position for the coordination of zinc
1 than for zinc 2. Zinc 1 is further from the carboxylate
oxygen, is more out of the plane of the carboxylate group
and interacts with the anti rather than the more favourable
syn lone pair [23] of the aspartic acid. Zinc 1 is also coordi-
nated by His54 Nε2, His56 Nδ1 and His110 Nε2, while
zinc 2 interacts with Asp58 Oδ1, His59 Nε2 and His173
Nε2. These residues come from four different regions of
the first domain. Superposition of the two β sheets upon
one another using the twofold rotation mentioned above
brings His54 onto His173. These residues are also
matched by a structure-based sequence alignment of the
two sheets. In the cacodylate-bound structure, the coordi-
nation sphere of each metal is completed by the two
oxygen atoms of the cacodylate ion interacting with the
two metal ions, respectively (Figure 4a). This gives each
of the two zinc ions an octahedral coordination. When glu-
tathione is present in the active site, another water mole-
cule is situated 2.5 Å from zinc 1 and the sulphur of the
glutathione is positioned 2.8 Å from zinc 2 in similar posi-
tions to the two oxygens of the cacodylate ion (Figure 4b).
In the HBPC–GSH complex the carbonyl oxygen of the
substrate analogue replaces the water molecule bound to
zinc 1 when glutathione is present and the sulphur is a
little further from zinc 2 (Figure 4c, Table 1). Despite the
differences in the coordination there is very little change
in the positions of the liganding residues and the coordina-
tion can be described as octahedral or square pyramidal.
Though it is more common that zinc ions in protein struc-
tures have a tetrahedral coordination, they often have a
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Figure 3
Stereoview of the electron density in the active
site of the HBPC–GSH complex. The density
is calculated with coefficients 2mFobs–dFcalc
using the final structure and contoured at 1σ.
The ligand is shown with orange carbon atoms
and protein residues are shown with khaki
carbon atoms. Although the density for the
phenyl group is poor, it is clear how the ligand
binds. The γ-glutamate of the HBPC–GSH is
not shown beyond the carbonyl oxygen. The
figure was prepared in O.
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Table 1
Distance from metals of coordinating residues in human glyoxalase II.
Metal Coordinating atom Complex with cacodylate Complex with HBPC–GSH Second sphere ligand
Residue Atom A B A B
Zn 1 His54 Nε2 2.31 2.23 2.15 2.14 Thr53 Oγ1
Zn 1 His56 Nδ1 2.32 2.24 2.21 2.23 Wat–Asp 146 Oε2*
Zn 1 His110 Nε2 2.25 2.25 2.13 2.14 Lys143 O
Zn 1 Asp134 Oδ2 2.21 2.31 2.58 2.57 Asp134 O
Zn 1 CAC/Wat2 O/OZ1 2.23 2.01 2.50 3.28
HBPC–GSH†
Zn 1 Wat1 O 2.12 2.14 2.00 2.00
Zn 2 Asp58 Oδ2 2.34 2.22 2.29 2.26 Bridging water
Zn 2 His59 Nε2 2.16 2.05 2.10 2.08 Asp29 Oδ2
Zn 2 Asp134 Oδ2 2.07 2.14 2.09 2.08 Asp134 O
Zn 2 His173 Nε2 2.12 2.08 2.13 2.15 Asp11 Oδ1
Zn 2 CAC/GSH† O1/S 2.37 2.37 2.86 3.32
Zn 2 Wat1 O 2.11 1.92 2.16 2.03
*Water molecule in turn hydrogen bonded to Asp146. †See text.
higher coordination number when present in catalytic
sites [24], particularly when part of a zinc cluster [25]; for
example, both leucine aminopeptidase [26] and purple
acid phosphatase [27] contain an octahedrally coordinated
zinc ion as part of a binuclear metal cluster. Each of the
residues liganding the zinc ions in glyoxalase II are sta-
bilised by either direct or indirect hydrogen-bonding
interactions with other residues (Table 1). 
Although the zinc-binding site in glyoxalase II is similar to
that observed in the metallo-β-lactamases, it is not identi-
cal. Indeed, the zinc-binding site is not completely con-
served among the metallo-β-lactamases from the three
species from which the structure has been elucidated. All
of the structures contain a histidine at the equivalent of
positions 54, 56, 110 and 173 in glyoxalase II and an aspar-
tic acid at position 58. The variation comes at the other
two residues. Asp134 is replaced by a cysteine in the
metallo-β-lactamases from B. fragilis and Bacillus cereus
and by a serine in the enzyme from Stenotrophomonas mal-
tophili. When the residue is a cysteine, it only coordinates
zinc 2 [16], and when a serine, it interacts with the zinc ion
only through an intervening water molecule [17]. Zinc 2 is
the zinc ion that is in a more favourable position for inter-
acting with Asp134 in glyoxalase II. In the metallo-β-lacta-
mases from B. fragilis and B. cereus, His59 is replaced by a
cysteine and an arginine, respectively. Neither of the
latter residues are in positions to coordinate the zinc ion.
In both the metallo-β-lactamases from B. fragilis and 
S. maltophili there is a water molecule shared between the
two metal ions as seen in glyoxalase II. In the enzyme
from B. cereus, however, the situation is slightly different
and the enzyme is able to bind either one or two metal
ions. Where there are two zinc ions in the active site, there
is also a shared water molecule but it is much closer to one
of the zinc ions than the other [28,29]. Recently, a model
for the zinc-binding site in glyoxalase II was proposed
based on the structure of the B. fragilis enzyme [18].
Although the model correctly predicted six out of seven of
the residues binding the zinc ion as well as the shared
water molecule, the modellers did not foresee either that
His59 would be a zinc ligand or that Asp134 would inter-
act with both metal ions. In the metallo-β-lactamases, the
coordination of the metal ions has been described as tetra-
hedral and distorted trigonal bipyramidal for zincs 1 and 2,
respectively [16,17]. The geometry around zinc 2, however,
is similar to that of the equivalent ion in glyoxalase II if the
active site ligands are excluded from the analysis. Whereas
for the S. maltophili metallo-β-lactamase, angles of 146°,
102° and 166° are given for the Wat1–Zn2–His255,
His255–Zn2–His89 and Asp88–Zn2–Wat2 angles, respec-
tively [17]; the corresponding angles in glyoxalase II are
~150° (Wat1–Zn2–His173), ~105° (His173–Zn2–His59) and
~164° (Asp58–Zn2–Asp134). 
Substrate-binding site
The glutathione moiety of HBPC–GSH is tightly bound
to the protein via its glycine and cysteine residues
(Figure 5a,b). In contrast, the γ-glutamate does not make
any specific interactions with the protein beyond its car-
bonyl oxygen atom and it is disordered in the electron
density. This agrees with previous studies that indicate
that the γ-glutamate is not necessary for binding [30]. It
differs, however, from the situation observed in glyoxalase
I, where with the same ligand both the glycine and γ-glu-
tamate residues are involved in hydrogen-bonding inter-
actions with the protein [31]. There are three basic
residues in proximity to the carboxylate group of the
glycine: Arg249, Lys252 and Lys143 (Figure 5). Arg249
and Lys252 are within hydrogen-bonding distance of the
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Figure 4
Metal coordination in glyoxalase II. (a) The complex with cacodylate.
(b) The molecule with GSH bound. (c) The molecule with
HBPC–GSH bound. The protein residues are shown with brown
carbon atoms and the ligands with red carbon atoms. Only the Cα, Cβ
and S atoms of the cysteine moiety of the GSH and HBPC–GSH are
shown. The figure was generated in MolScript version 2.1 [54] and
rendered in Raster3D [55]. 
carboxylate. These residues belong to the final α helix of
the second domain. Arg249 is anchored in position by
further hydrogen-bonding interactions with the carboxy-
late of Asp253 and the carbonyl oxygen of Cys141. The
hydrophobic part of the Lys252 sidechain packs against
the phenyl ring of Phe180. Lys143 is situated a little
further from the carboxylate and instead hydrogen bonds
to the carbonyl oxygen of the γ-glutamate. This residue is
situated just after the β hairpin. The carbonyl oxygen of
Cys141, which is situated on the hairpin, interacts with
the glutathione via a water molecule. The glutathione
makes further interactions with Tyr175 and Tyr145, the
details of which can be seen in Figure 5b. 
The S-hydroxybromophenylcarbamoyl (HBPC) binds
over the zinc site with its phenyl ring stacking against the
imidazole ring of His56. Based on the lower KM of S-man-
deloylglutathione than that of S-lactoylglutathione it had
been proposed that glyoxalase II would have a hydropho-
bic pocket for substrate binding [11,30,32] such as occurs
in glyoxalase I [10]; however, there is no such pocket and
the bromophenyl group of the HBPC–GSH binds in a
groove in the protein and is completely accessible to
solvent. The hydroxycarbamoyl group adopts a trans con-
formation above the binuclear zinc site such that the zinc-
bound water molecule is 2.9 Å from the C1 atom in a
direction perpendicular to the plane of the hydroxycar-
bamoyl and the carbonyl oxygen is 3.3 Å from zinc 1, as
described previously. The hydroxyl oxygen of the ana-
logue is not involved in hydrogen bonding. It has, in fact,
been shown that there is no requirement for substrates to
have a hydroxyl group at this position [33]. These are the
only close interactions made by the S-substituent of glu-
tathione and it would appear that the molecular recogni-
tion is through the glutathione moiety and the interactions
of the thiolester group with the zinc ions. The absence of
close contacts with the protein may explain why the
density is less well defined for the HBPC than for the glu-
tathione moiety (Figure 3). It is also possible, however,
that the HBPC–GSH has undergone some hydrolysis, as
this molecule is a slow substrate for glyoxalase II [19]. 
In the molecule in which glutathione has bound in the
active site, it adopts a very similar conformation to the
equivalent moiety of the HBPC–GSH. The proximity of a
crystallographically related molecule would appear to
prevent the HBPC–GSH from binding in this molecule of
the asymmetric unit. When acetate binds in the active
site, it mimics the glycine carboxylate group of the glu-
tathione. There are no significant differences in main-
chain conformation among the structures with GSH
bound, with HBPC–GSH and with cacodylate and acetate
ions bound. Although we do not have a true nonliganded
structure with which to compare, the absence of any con-
formational changes among the various molecules, crys-
tallised under slightly different conditions, agrees with
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Figure 5
View of the active site in glyoxalase II. (a) Residues coordinating the
zinc ion or those within hydrogen-bonding distance of the
HBPC–GSH are represented as balls and sticks with yellow carbon
atoms. The HBPC–GSH is shown as a ball-and-stick representation
with orange carbon atoms. The surrounding schematic view of the
backbone is coloured as in Figure 2a. The HBPC–GSH is truncated
as in Figure 3. (b) Schematic diagram showing the interactions
between the HBPC–GSH and the protein. The ligand is shown with
purple bonds and the protein residues with brown bonds. Atoms and
residues involved in hydrophobic contacts are shown as fanned by red
dashes. The figure was made using LIGPLOT [56]. 
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the results from limited proteolysis [21]. There is no
equivalent in glyoxalase II of the flexible loop in the
metallo-β-lactamases that has been proposed to fold over
the active site when substrate binds [34]. 
Conservation
To date there are a total of seven sequences that are known
to encode glyoxalase II enzymes. A BLAST search [35]
located other sequences with similarity to glyoxalase II.
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Sequence conservation among the glyoxalase II enzymes. The
sequences were aligned using ClustalW [37]. Human, Homo sapiens,
SWISS-PROT accession no. Q16775; Marmoset, Callithrix jacchus,
SWISS-PROT accession no. Q28333; Rat, Rattus norvegicus
GENBANK accession no. U97667; A. thaliana, Arabidopsis thaliana,
EMBL accession no. Y08357; S_mansoni, Schistosoma mansoni,
SWISS-PROT accession no. Q26547; C_elegans, Caenorhabditis
elegans, EMBL accession no. AL023828; Yeast_glo2, Saccharomyces
cerevisiae, SWISS-PROT accession no. Q05584; Yeast_glo4,
Saccharomyces cerevisiae, SWISS-PROT accession no. Q12320;
R_capsulatus, Rhodobacter capsulatus, EMBL accession no. X99599;
R_blasticus, Rhodobacter blasticus, SWISS-PROT accession no.
P05446; A_thaliana_mit, Arabidopsis thaliana, GENBANK accession
no. U90927 (mitochondrial); E_coli, Escherichia coli, SWISS-PROT
accession no. Q47677; B_aphidicola, Buchnera aphidicola,
SWISS-PROT accession no. Q08889; Synechocystis, Synechocystis
PCC6803, SWISS-PROT accession no. P72933; S_pombe,
Schizosaccharomyces pombe, EMBL accession no. AL032681;
H_influenzae, Haemophilus influenzae, SWISS-PROT accession no.
P71374. Numbering corresponds to the human enzyme. The
secondary structure is as shown in Figure 2. Vertical lines indicate the
ends of the two β sheets of the sandwich. Residues that are identical
to at least 14 out of the other 15 matched residues are coloured red
and those identical to more than 11, blue. Residues that are conserved
but not identical are coloured green. Conservation was calculated in
ALSCRIPT [57] with a value of 6. The residues that coordinate zincs 1,
2 or both are denoted by Z1, Z2 and ZB, respectively. Residues within
hydrogen-bonding distance of the GSH are shown by G. GM denotes
that the glutathione interacts with the mainchain of the residue. 
The sequences that we believe are most likely to encode
glyoxalase II enzymes have been aligned in Figure 6. This
is fewer than in a sequence alignment reported by Bito et
al. [36] since many of these sequences, when aligned using
ClustalW [37], appear to lack the residues at the C termi-
nus that interact with glutathione. The conserved residues
are mainly involved in formation of either the metal-
binding or the substrate-binding sites (Figure 7). Apart
from the A. thaliana mitochondrial sequence, there is com-
plete conservation of the seven residues directly involved
in metal coordination as well as most of the key residues
that are involved in glutathione binding (Arg249, Lys252,
Tyr175 and Asn179). Lys43, however, is replaced in the
majority of sequences by an arginine. In the sequence from
A. thaliana mitochondria, His173, coordinated to zinc 2, is
replaced by an arginine, Tyr175 by an asparagine, Arg49 by
a glutamine, Lys252 by an arginine and Lys143 by a serine.
Despite these changes among the important residues, Maiti
et al. reported glyoxalase II activity [38]. It seems, there-
fore, that these concerted changes allow the enzyme to
bind glutathione derivatives. These workers did report,
however, that the activity of the mitochondrial enzyme was
much lower than that of the cytoplasmic enzyme. They
postulated that this was because of problems in expression;
however, it could be that this enzyme does not bind glu-
tathione as well as the others.
Most of the other conserved residues also contribute to
the formation of the active site. The sidechains of Asn12,
Asp29 and Thr53 are all involved in hydrogen bonding
with the metal-coordinating residues. Thr111, Gly133 and
Glu174 are important in positioning the mainchain of the
neigbouring zinc ligands. The GCG motif including
residues 140–142 belongs to the β hairpin (Figure 7). This
motif seems critical in maintaining the active site. A Cβ
atom at residue 140 would clash with Asn179, resulting in
a disruption of the glutathione-binding site. Similarly, any
residue other than a glycine at position 142 would clash
with Asp134, one of the metal ligands. The sulphur of
Cys141 in this motif is in van der Waals contact distance
of the sidechains of Arg249, Met152 and Phe224, which
are all conserved. Residues Glu218 and Asn222, which
belong to the second domain, hydrogen bond to the
β hairpin and presumably stabilise its structure. Again, the
sequence alignment suggests that mitochondrial
A. thaliana glyoxalase II must have a slightly different
active site. It is possible that the hydroxyl of the serine
corresponding to Gly140 of the human enzyme will
occupy the space occupied by the water molecule binding
to glutathione that is seen in each of the molecules of our
structures. The phenyl rings of Phe182 and Tyr145 seem
to be important in stabilising Lys252 and Lys143, respec-
tively, by stacking interactions with the hydrophobic
sidechains of these residues. In the structure, the
hydroxyl of Tyr145 is 3.3 Å from the carbonyl oxygen of
the glycine moiety of the glutathione (Figure 5b) but in
most sequences the tyrosine is replaced by a phenylala-
nine. Other conserved residues are involved in the forma-
tion of the hydrophobic core or are found in sharp turns.
Reaction mechanism 
Like glyoxalase I, the first enzyme in the glyoxalase
pathway, glyoxalase II is a very efficient enzyme with a
kcat/KM close to the diffusion limit using S-D-lactoylglu-
tathione as substrate [39]. It has a broad pH optimum,
with the enzyme isolated from human liver showing no
variation in activity between pH 6.8 and 7.5. The reaction
is thought to involve a nucleophilic attack on the C1 atom
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Figure 7
Stereoview of glyoxalase II coloured
according to conservation as shown for the
glyoxalase sequence in Figure 6. The metal
ions and the coordinating residues are shown.
The HBPC–GSH is shown in orange. The
figure was prepared in ALSCRIPT. 
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of the substrate [32]. The structure shows a clear candi-
date for the nucleophile in the reaction. The water mole-
cule that is coordinated to the two zinc ions is situated
below the plane of the carbonyl bond of the HBPC–GSH,
2.9 Å from the C1 atom, in a stereochemically ideal posi-
tion for attack. Since the HBPC–GSH is a slow substrate
for glyoxalase II and the true substrate of the reaction is
little different [19], it seems likely that this water mole-
cule is indeed the nucleophile. Presumably, the interac-
tion of the water molecule with the two zinc ions, would
lower its pKa sufficiently for it to exist in the form of a
hydroxide and alleviate the need for a base to abstract a
proton. In addition to coordinating the zinc ions, the water
molecule is within hydrogen-bonding distance of the Oδ1
atom of Asp58 (Table 1 and Figure 4). Asp58 is unlikely to
play any role in proton transfer because of the interaction
between its Oδ2 atom and zinc 2, but will help orient the
hydroxide for attack and modify its pKa. By analogy with
other metallo-hydrolases, nucleophilic attack would pre-
sumably result in a negatively charged tetrahedral inter-
mediate. There are no protein residues near to the
carbonyl oxygen of the HBPC–GSH that can help sta-
bilise this intermediate. The hydroxyl of Tyr145 is 4.1 Å
from the oxygen, but it is not conserved among the glyox-
alase II enzymes and is not in a good position for hydrogen
bonding. The carbonyl oxygen is, however, only 3.3 Å
from zinc 1. For leucine aminopeptidase, another binu-
clear zinc enzyme, a reaction has been suggested in which
a hydroxide shared between two zinc ions attacks the sub-
strate to form an intermediate in which the two oxygen
atoms are coordinated to the zinc ion [26]. Although there
is no direct evidence that this occurs in glyoxalase II, it is
possible to model the putative transition-state structure
with both oxygen atoms interacting closely with zinc 1.
This interaction will provide the necessary stabilisation of
the negative charge. To complete the reaction, the C1–S
bond must be broken, the glutathione protonated and the
products must diffuse from the active site to be replaced
by water molecules. Without further information it is diffi-
cult to say how this occurs. In the structure, however, the
sulphur atoms of the HBPC–GSH and GSH are 3.3 Å and
2.9 Å, respectively, from zinc 2. One possibility, therefore,
is that the zinc ion will stabilise a thiolate ion formed upon
bond breakage. Tyr175 could also play a part in the reac-
tion mechanism. Its hydroxyl oxygen is positioned 3.6 Å
from the sulphur; however, chemical modification studies
suggest that a tyrosine is not important in the mechanism
[32]. A possible reaction scheme is given in Figure 8.
This reaction scheme supports the mechanism proposed
for the binuclear metallo-β-lactamases in the hydrolysis of
the amide bond of β-lactams. This scheme involves the
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Figure 8
A reaction mechanism for glyoxalase II
proposed on the basis of the position of
HBPC–GSH in the active site. GSH represents
reduced glutathione (γ-L-Glu-L-Cys-Gly). The
hydroxide ion is next to the carbonyl carbon,
zinc 1 close to the carbonyl oxygen and zinc 2
near the sulphur of the HBPC–GSH. The
hydroxide attacks the carbonyl carbon to form a
negatively tetrahedral intermediate that may be
stabilised by coordination to zinc 1. The C–S
bond then breaks to yield the product.
Presumably, in the apo enzyme, the sixth
coordination positions of the zinc ions will be
taken up by water molecules but these are not
shown in the diagram. 
nucleophilic attack of the shared hydroxide on the car-
bonyl carbon of the β-lactam [16,17]. The interaction of
the hydroxide with an aspartic acid seen in glyoxalase II is
conserved in the metallo-β-lactamases. For the metallo-β-
lactamases it has proved difficult to obtain a crystal struc-
ture in complex with a substrate analogue [17]. Computer
simulations of the binding of β-lactams to the metallo-β-
lactamases, however, result in models in which the car-
bonyl oxygen and nitrogen of the β-lactam interact with
zincs 1 and 2, respectively, and the carbonyl carbon is situ-
ated above the shared hydroxide [16,17]. This mimics the
situation observed in glyoxalase II but the nitrogen of the
amide bond takes the position of the sulphur of the thio-
lester bond. Our structure, therefore, provides experimen-
tal evidence to corroborate the results of the
computer-simulated binding studies of the metallo-β-lac-
tamases and consequently supports the reaction mecha-
nism put forward for these enzymes. 
Biological implications
The glyoxalase system catalyses the detoxication of
methylglyoxal, which is produced as an unavoidable
byproduct of glycolysis. The system consists of two
enzymes, glyoxalase I and glyoxalase II, which work in
concert using glutathione as a coenzyme to convert
methylglyoxal or other 2-oxoaldehydes to 2-hydroxycar-
boxylic acids. Although the enzymes interact with glu-
tathione derivatives, they are not structurally similar to
other glutathione-linked enzymes of known structure.
Instead, the two enzymes have been shown to belong to
two distinct evolutionary classes. Glyoxalase II catalyses
the hydrolysis of the thiolester bond of S-D-lactoylglu-
tathione to form D-lactate and glutathione. It has
recently been shown to have sequence similarity to other
hydrolases, including the metallo-β-lactamases. Here, we
describe the structure of human glyoxalase II in complex
with a substrate analogue. The structure not only allows
us to postulate a mechanism for the catalysed reaction,
which may be relevant to many members of the family,
but provides another example of how glutathione inter-
acts with proteins. A detailed knowledge of the active
site may also be useful in the design of inhibitors of the
enzyme that can be used in further probing the function
of the enzyme. 
The structure consists of two domains. The N-terminal
domain shows the expected similarity with the metallo-β-
lactamases, a four-layered β sandwich containing a binu-
clear zinc-binding site at one edge. The C-terminal
domain, on the other hand, is unique to glyoxalase II and
consists mainly of α helices. The substrate analogue
binds at the domain interface with the glycine and cys-
teine residues of the glutathione moiety involved in
hydrogen-bonding interactions with the protein. In con-
trast to other glutathione-linked enzymes, the carboxy-
late group of the γ-glutamate does not make any specific
contacts with the protein. The position of the reactive
centre of the ligand 2.9 Å from a water molecule coordi-
nated to two zinc ions suggests that this water molecule,
presumably in the form of a hydroxide ion, will act as the
nucleophile in the reaction. 
Materials and methods
Complex with acetate and cacodylate
Recombinant protein was expressed and purified as described previ-
ously [12]. Crystals were grown in hanging drops. To obtain the crys-
tals for the native and derivative data sets, well liquor including
15–30% w/v PEG 2000 monomethyl ether, 0.2 M Mg-acetate, 0.1 M
Na-cacodylate pH 6.5, and 2 mM DTT was mixed with an equal volume
(5 µl) of 10 mg/ml glyoxalase II in 10 mM MOPS pH 7.1, containing
10 mM MgCl2 and 25% PEG 400.
X-ray data collection statistics can be seen in Table 2. All data were
collected from crystals flash frozen in a nitrogen gas stream at 100K.
The low-resolution native and derivative data sets were collected on a
Rigaku R-AXIS mounted on a rotating-anode X-ray source. The high-
resolution native data set was collected on a MAR research imaging
plate on EMBL beamline X11 at DESY, Hamburg. Data were
processed and scaled with the HKL suite of programs [40]. Further
processing was carried out using programs from the CCP4 package
[41]. The space group was determined to be P212121, with two mole-
cules in the asymmetric unit. One mercury derivative, utilising the anom-
alous signal, was sufficient to solve the structure. The low-resolution
native data set was used during structure solution. Initial heavy-atom
sites were located using difference Patterson methods. Following
refinement of the heavy-atom parameters in SHARP [42], the calcu-
lated phases were used to find minor sites. Phases were improved
using DM [43] including solvent flattening, histogram matching and
twofold averaging. The resulting map was of high quality so that a com-
plete model could be built using skeletonised density, mainchain and
sidechain databases and baton building methods [44,45]. 
Refinement was carried out against the high-resolution native data set
initially in CNS [46] using the slow-cool procedure [47] and torsion-
angle dynamics [48], and later in REFMAC [49]. All data between 15
and 1.9 Å were used in the refinement. During the initial cycles strict
noncrystallographic-symmetry constraints were applied between the
two molecules of the asymmetric unit and in later cycles these were
replaced with restraints. The progress of refinement was monitored with
5% of the data set aside to calculate Rfree [20]. Water molecules were
located with ARP [50]. During the rebuilding stages it was apparent
that there was a binuclear metal-binding site and zinc ions were
inserted into the corresponding density. Other density observed in the
active sites was modelled as acetate and cacodylate ions, respectively.
A large peak was also observed in difference maps next to Cys153.
This was presumed to be cacodylate covalently linked via an As–S
bond but only the arsenic atom of the cacodylate was modelled.
Density seen at the interface between the two molecules was assigned
to be Mn and Cl ions. For the final structure, the rmsd from ideal bond
lengths and angle distances [51] are 0.008 Å and 0.024 Å, respec-
tively, and the rms B value between bonded atoms is 2.1 Å2. Only 2.3%
of residues are outliers in a stringent boundary Ramachandran plot [52].
The average temperature factor of the protein is 19 Å2, whereas those
for the four zinc ions are 20, 19, 19 and 18 Å2 for zincs 1 and 2 of the A
and B molecules, respectively. The cacodylate ions have average tem-
perature factors of 40 Å2 and the acetate ions of 20 Å2. 
Complex with HBPC–GSH 
Crystals were again grown in hanging drops. The protein solution, con-
taining 15 mg/ml enzyme in 10 mM MOPS pH 7.1 and 25% PEG 400,
was equilibrated against the well liquor, which contained 4–20% PEG
2000 monomethyl ether, 0.1 M Na imidazole pH 6.5 and 2 mM DTT.
The crystals were then soaked for a period of 1 hr 30 min in a solution
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containing 20 mM HBPC–GSH, 30% PEG 400 and 2 mM DTT
buffered with MOPS at pH 7.1. Data were collected from frozen crys-
tals on a Quantum-4 CCD detector at beamline ID14-EH4 at the
ESRF, Grenoble and processed as above. Refinement was carried out
in REFMAC using all data between 20 and 1.45 Å. The starting model
for refinement included all protein atoms of the refined native structure.
Water molecules were located with ARP. No noncrystallographic-sym-
metry restraints were imposed during refinement. HBPC–GSH was
modelled in one molecule of the asymmetric unit and GSH in the other.
For the final structure, the rmsd from ideal bond lengths and angle dis-
tances [51] are 0.011 Å and 0.026 Å, respectively, and the rms B value
between bonded atoms is 2.1 Å2. Only 1.7% of residues are outliers in
a stringent boundary Ramachandran plot [52]. The average tempera-
ture factor of the protein is 21 Å2, whereas those for the four zinc ions
are 18, 17, 15 and 15 Å2 for zincs 1 and 2 of the A and B molecules,
respectively. The HBPC–GSH has an average temperature factor of
31 Å2 and the GSH of 33 Å2.
Analysis
All superpositions were carried out in O such that all matching Cα
pairs were less than 3.8 Å apart after the superposition. Solvent-acces-
sibility calculations were performed in X-PLOR [53]. 
Metal analysis
Metal analyses were carried out by inductively coupled plasma atomic
emission spectrometry and covered 11 elements (Al, Ca, Co, Cr, Cu,
Fe, Mg, Mn, Mo, Ni and Zn). The protein used in the assay was purified
as above but with the addition that all buffers were treated with Chelex-
100 (Bio-Rad Laboratories Inc., Hercules, Ca, USA). 
Accession numbers
Coordinates and structure factor amplitudes have been deposited in
the PDB with entry codes 1qh3 and 1qh5 for the complexes with
cacodylate and HBPC–GSH, respectively. 
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